These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29127747)

  • 41. A patient-centred approach to treatment with incretin-based agents in patients with type 2 diabetes.
    Cornell SA
    J Clin Pharm Ther; 2013 Jun; 38(3):181-9. PubMed ID: 23442106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ADA/EASD position statement of the treatment of type 2 diabetes: Reply to Rodbard HW and Jellinger PS [letter], Scheen AJ [letter] and Ceriello A, Gallo M, Gentile S et al [letter].
    Matthews DR; Inzucchi SE;
    Diabetologia; 2012 Oct; 55(10):2856-2857. PubMed ID: 22854891
    [No Abstract]   [Full Text] [Related]  

  • 43. How well we treat with insulin in the Czech Republic and in the Slovak Republic A summary of results and comments on the original Czech-Slovak DIAINFORM study.
    Brož J; Žďárská DJ; Urbanová J; Doničová V; Martinka E; Kvapil M
    Vnitr Lek; 2019; 65(4):279-283. PubMed ID: 31091947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes mellitus in complex older patients.
    Šmahelová A
    Vnitr Lek; 2018; 64(11):1005-1008. PubMed ID: 30606016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New oral antidiabetic drugs].
    Féry F
    Rev Med Brux; 2014 Sep; 35(4):347-55. PubMed ID: 25675642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early therapy for type 2 diabetes in China.
    Yang W; Weng J
    Lancet Diabetes Endocrinol; 2014 Dec; 2(12):992-1002. PubMed ID: 25218729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diabetes mellitus and cognitive disorders from the diabetologists perspective].
    Šmahelová A
    Vnitr Lek; 2017; 63(10):717-720. PubMed ID: 29127756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metformin in the era of new antidiabetics.
    Rajjoub Al-Mahdi EA; Barrios V; Zamorano JL
    Future Cardiol; 2021 May; 17(3):475-485. PubMed ID: 33754810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.
    Staiger H; Schaeffeler E; Schwab M; Häring HU
    Rev Diabet Stud; 2015; 12(3-4):363-76. PubMed ID: 27111121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Management of patients with type 2 diabetes at cardiovascular and renal risk : ESC versus ADA-EASD].
    Scheen AJ; Paquot N
    Rev Med Suisse; 2020 Aug; 16(703):1478-1482. PubMed ID: 32852167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of different approaches for estimation of prevalence of type 2 diabetes mellitus in the Czech Republic.
    S PHM; Škodová M; Kučová P; Votápková J
    Vnitr Lek; 2020; 66(5):69-71. PubMed ID: 32942873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Precision medicine: The future in diabetes care?
    Scheen AJ
    Diabetes Res Clin Pract; 2016 Jul; 117():12-21. PubMed ID: 27329017
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pharmacogenetics of oral antidiabetic treatment].
    Tkáč I
    Vnitr Lek; 2016 Mar; 62(3):186-8. PubMed ID: 27180666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Trends in the representation of specialties caring for patients with diabetes in the Czech Republic.
    Kvapil M; Nováková M; Benešová K; Jarkovský J; Dušek L
    Cas Lek Cesk; 2024; 163(3):115-119. PubMed ID: 38981733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [New understanding of the problem of management of type 2 diabetes mellitus - novel prospects (ADA/EASD consensus, 2008)].
    Biryukova EV
    Probl Endokrinol (Mosk); 2009 Dec; 55(6):3-7. PubMed ID: 31569882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Realistic possibilities of using data sources in quality assessment of care of patients with diabetes in the Czech Republic: National Diabetes Information System].
    Kvapil M
    Vnitr Lek; 2015 Nov; 61(11 Suppl 3):3S10-3. PubMed ID: 26652959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidiabetic Drugs in Breast Cancer Patients.
    Garczorz W; Kosowska A; Francuz T
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 Diabetes.
    Vieira IH; Barros LM; Baptista CF; Rodrigues DM; Paiva IM
    Clin Diabetes; 2022 Jan; 40(1):97-107. PubMed ID: 35221479
    [No Abstract]   [Full Text] [Related]  

  • 59. Are gliflozins the new statins for diabetes?
    Giugliano D; Maiorino MI; Longo M; Esposito K
    Diabetes Res Clin Pract; 2019 Jul; 153():191-193. PubMed ID: 30959149
    [No Abstract]   [Full Text] [Related]  

  • 60. Combination lipid therapy in type 2 diabetes.
    Clearfield M
    Curr Atheroscler Rep; 2011 Feb; 13(1):1-3. PubMed ID: 21086075
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.